Diagnosis and staging of pancreatic ductal adenocarcinoma.
Por:
Guillén-Ponce C, Blázquez J, González I, de-Madaria E, Montáns J and Carrato A
Publicada:
1 oct 2017
Ahead of Print:
13 jun 2017
Resumen:
The management of pancreatic ductal adenocarcinoma (PDAC) is a major public health concern worldwide. Currently, most PDAC patients are diagnosed in advanced stages. The signs and symptoms of the disease, except for jaundice, are non-specific. Thus, the current challenge is to identify earlier those individuals for whom specific screening tools and specific treatments would be beneficial. On the basis of the recommendations of the group of experts of multiple medical specialties of the GALLgo Project, the patients with PDAC should be managed by a multidisciplinary team to assess the personal and family history, the best diagnostic and staging procedures and consider all important aspects for treatment decisions. In this article, the group of experts proposes strategies to shorten the diagnosis times in PDAC patients.
Filiaciones:
Guillén-Ponce C:
Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo, km 9,100, Madrid, Spain.
Blázquez J:
Department of Radiology, Hospital Universitario Ramón y Cajal, Madrid and Hospital MD Anderson, Madrid, Spain
González I:
Department of Medical Oncology, Complejo Hospitalario de Granada, Granada, Spain
:
Pancreatic Unit, Gastroenterology Department, Hospital General Universitario de Alicante, Alicante, Spain
Montáns J:
Department of Pathology, Centro Anatomopatológico, Madrid, Spain
Carrato A:
Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo, km 9,100, Madrid, Spain
|